Condition

Ovarian Cancer Recurrent clinical trials and research

• 7Clinical trials
• 10Countries

Newest Ovarian Cancer Recurrent clinical trials

All recruiting trials (7)

• OPB-201 therapy for recurrent endometrial and platinum-resistant ovarian cancer

  A one-time treatment with a patient’s own T cells engineered to target PRAME is being tested to see if it is safe and what dose works best for adults with recurrent endometrial cancer or platinum-resistant ovarian cancer.

  Recruiting at 5 sites Phase 1 Outpace Bio, Inc. · San Francisco, California and 4 other locations · NCT07664735

• New treatment for relapsed high-grade serous ovarian cancer

  This study is testing a new drug combined with standard treatments to see if it can help people with relapsed high-grade serous ovarian cancer feel better and manage their disease.

  Recruiting at 40 sites Phase 1/2 Merck Sharp & Dohme LLC · New Haven, Connecticut and 40 other locations · NCT06843447

• Combining pegylated liposomal doxorubicin and adebrelimab with or without mirabegron for relapsed ovarian cancer

  This study is testing a new treatment combination for adults with relapsed ovarian cancer to see if adding mirabegron to pegylated liposomal doxorubicin and adebrelimab makes it work better.

  Recruiting Phase 2/3 Obstetrics & Gynecology Hospital of Fudan University · Shanghai, Shanghai Municipality · NCT06791460

• Exploring personalized treatment for recurrent gynecological cancers

  This study is testing if using genetic information to guide treatment can help improve outcomes for people with recurrent ovarian, cervical, or endometrial cancer.

  Recruiting at 2 sites Sun Yat-sen University · Guangzhou, Guangdong and 1 other locations · NCT06781151

• Treatment for platinum-resistant recurrent ovarian cancer using IN10018 and PLD

  This study is testing whether a new treatment combining IN10018 with a standard cancer drug can help people with platinum-resistant recurrent ovarian cancer feel better compared to a placebo.

  Recruiting Phase 2 InxMed (Shanghai) Co., Ltd. · Beijing · NCT06014528

• Using SBRT and Niraparib for Ovarian Cancer with Limited Progression

  This study is testing if combining a type of targeted radiation therapy with a cancer medication can help women with advanced ovarian cancer that has only spread a little bit feel better and live longer.

  Recruiting at 7 sites Phase 2 Institute of Cancer Research, United Kingdom · Leeds, Leeds and 6 other locations · NCT05990192

• Surgery and Niraparib for recurrent ovarian cancer

  This study is testing whether surgery followed by chemotherapy and a drug called Niraparib can help people with recurrent ovarian cancer do better than just chemotherapy alone.

  Recruiting Phase 2 Shanghai Gynecologic Oncology Group · Shanghai, Shanghai Municipality and 4 other locations · NCT03983226

Related topics

Quick answers

How many Ovarian Cancer Recurrent clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 10 countries. The most sites are in China (4 trials), United States (2 trials), United Kingdom (2 trials), Australia (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 2/3: 1, Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →